Pharmaceutical companies operate under some of the most detailed regulation of any sector in this corpus. This file asks what it covers.
It Governs The Record And Not The Network
Data integrity requirements specify how records must be created, attributed, contemporaneous and unalterable. Trial conduct rules govern consent, protocol and reporting. Manufacturing validation governs the equipment and the process.
None of that is a security regime in the sense this database uses. It asks whether a record is trustworthy, not whether an adversary could reach the system holding it.
The corpus filed the same shape at 25-0601 for insurance — supervision attaching to solvency and conduct rather than to third-party platform security — and at 25-0720 for telecom, where subscriber identification rules produced bank-grade records under a communications regulator.
And The CRO Sits Outside Both
A contract research organisation is subject to trial conduct rules for the work it performs. Whether its corporate network is defensible is, per 25-0914b, not something this desk could establish that any regulator examines.
DORA at 25-0117 remains the one instrument in this corpus extending supervision to critical service providers, and it covers EU financial entities.
The Overlap That Does Exist Is Accidental And Useful
Data integrity rules require that records cannot be silently altered — which is, incidentally, an integrity control of exactly the kind 25-0921b argues nothing else in this corpus provides.
It is the aviation pattern at 25-0628 again: a regime built for safety producing a security property a security argument could not fund. Graded medium: this describes regulatory structure in general terms and no specific instrument has been reviewed.
It describes regulatory structure in general terms. It is not legal advice and no specific instrument has been reviewed by this desk. Corrections: corrections@forensicpost.com.